[VYNE] QoQ Quarter Result on 30-Sep-2019 [#Q3]

Stock
[VYNE] VYNE Therapeutics Inc.
Announcement Date
31-Oct-2019
Financial Year
2019
Quarter
30-Sep-2019 [#Q3]
Profit Trend
QoQ- -2.29%
YoY- -31.20%
Quarter Report
VYNE's Result
VYNE's Financial Summary
View:
Show?
Quarter Result
30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 CAGR
Revenue 11,688 1,750 0 0 0 0 -10,640 -
PBT -167,699 -40,233 -21,498 -16,855 -16,477 -18,873 -17,594 350.16%
Tax -259 728 -52,379 0 0 0 -11 723.07%
NP -167,440 -40,233 -21,498 -16,855 -16,477 -18,873 -17,594 349.70%
Tax Rate - - - - - - - -
Total Cost 179,128 41,983 21,498 16,855 16,477 18,873 6,954 773.93%
Ratio Analysis
30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 CAGR
NP Margin -1,432.58 -2,299.03 0.00 0.00 0.00 0.00 165.36 -
Per Share
30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 CAGR
EPS -86.95 -68.15 -64.36 -50.66 -49.65 -58.35 -54.68 36.27%
EPS Diluted -86.95 -68.15 -64.36 -50.66 -49.65 -58.35 -54.68 36.27%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.